—PAYX
— • —
$85.57
P/E
18.86
PEG
—
FCF Yield
—
Rev Growth YoY
+1644.0% YoY
Gross Margin
9137.0%
Health Score
5/10
D/E Ratio
1.20
Confidence
LOW
Business Snapshot
The company behind this ticker operates in an unspecified sector and industry, with exchange information absent from the payload. Based on the available valuation ratios and financial metrics, the stock is priced at $85.57 per share. Without market capitalisation data, the cap tier cannot be confirmed, though the combination of a P/E of 18.86x and Price/Sales of 4.91x suggests a company with meaningful revenue scale.
Financial Health
**Score: 5/10** The company's gross margin of 9,137% and net margin of 2,584% are extraordinary figures that likely reflect a very small or distorted revenue base, raising questions about the reliability or normalisation of these metrics rather than signalling genuine operational excellence. Debt/equity stands at 1.2x, which is manageable but not negligible, and the current ratio of 1.28x indicates the company can cover short-term obligations, though with limited headroom...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 9,137% and net margin of 2,584% are implausible for most businesses and likely indicate a distorted or near-zero revenue base, undermining the validity of margin analysis. - **EARNINGS DETERIORATION:** Earnings growth of -565% YoY despite revenue growth of +1,644% signals a severe disconnect between top-line and bottom-line performance. - **CASH FLOW OPACITY:** Free cash flow and FCF yield are both unavailable, making it impossible to assess whether the business generates real cash or relies on external funding. - **ANALYST CONSENSUS:** Only 4% of analysts rate the stock a Buy, with 68% on Hold and the consensus formally designated as Sell — a stark lack of institutional conviction. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates negative medium-term price momentum. ---...